JP2023502030A5 - - Google Patents

Info

Publication number
JP2023502030A5
JP2023502030A5 JP2022527713A JP2022527713A JP2023502030A5 JP 2023502030 A5 JP2023502030 A5 JP 2023502030A5 JP 2022527713 A JP2022527713 A JP 2022527713A JP 2022527713 A JP2022527713 A JP 2022527713A JP 2023502030 A5 JP2023502030 A5 JP 2023502030A5
Authority
JP
Japan
Prior art keywords
peaks
methyl
compound
crystalline
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022527713A
Other languages
English (en)
Japanese (ja)
Other versions
JP7726879B2 (ja
JP2023502030A (ja
Filing date
Publication date
Priority claimed from JP2019206311A external-priority patent/JP2021080177A/ja
Application filed filed Critical
Publication of JP2023502030A publication Critical patent/JP2023502030A/ja
Publication of JP2023502030A5 publication Critical patent/JP2023502030A5/ja
Priority to JP2025132388A priority Critical patent/JP2025159062A/ja
Application granted granted Critical
Publication of JP7726879B2 publication Critical patent/JP7726879B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022527713A 2019-11-14 2020-11-12 複素環式化合物およびその使用 Active JP7726879B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025132388A JP2025159062A (ja) 2019-11-14 2025-08-07 複素環式化合物およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019206311 2019-11-14
JP2019206311A JP2021080177A (ja) 2019-11-14 2019-11-14 複素環化合物及びその用途
PCT/IB2020/000962 WO2021094832A1 (en) 2019-11-14 2020-11-12 Heterocyclic nmda antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025132388A Division JP2025159062A (ja) 2019-11-14 2025-08-07 複素環式化合物およびその使用

Publications (3)

Publication Number Publication Date
JP2023502030A JP2023502030A (ja) 2023-01-20
JP2023502030A5 true JP2023502030A5 (enExample) 2023-11-20
JP7726879B2 JP7726879B2 (ja) 2025-08-20

Family

ID=74141594

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019206311A Pending JP2021080177A (ja) 2019-11-14 2019-11-14 複素環化合物及びその用途
JP2022527713A Active JP7726879B2 (ja) 2019-11-14 2020-11-12 複素環式化合物およびその使用
JP2025132388A Pending JP2025159062A (ja) 2019-11-14 2025-08-07 複素環式化合物およびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019206311A Pending JP2021080177A (ja) 2019-11-14 2019-11-14 複素環化合物及びその用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025132388A Pending JP2025159062A (ja) 2019-11-14 2025-08-07 複素環式化合物およびその使用

Country Status (21)

Country Link
US (2) US11834409B2 (enExample)
EP (1) EP4058430A1 (enExample)
JP (3) JP2021080177A (enExample)
KR (1) KR20220102629A (enExample)
CN (1) CN114728900A (enExample)
AR (1) AR120452A1 (enExample)
AU (1) AU2020385250A1 (enExample)
BR (1) BR112022008367A2 (enExample)
CA (1) CA3158352A1 (enExample)
CL (1) CL2022001241A1 (enExample)
CO (1) CO2022008012A2 (enExample)
CR (1) CR20220275A (enExample)
DO (1) DOP2022000099A (enExample)
EC (1) ECSP22037602A (enExample)
IL (1) IL292639A (enExample)
JO (1) JOP20220108A1 (enExample)
MX (1) MX2022005778A (enExample)
PE (1) PE20221767A1 (enExample)
PH (1) PH12022551173A1 (enExample)
TW (1) TWI908745B (enExample)
WO (1) WO2021094832A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL4031552T3 (pl) 2019-09-16 2025-03-17 Takeda Pharmaceutical Company Limited Pochodne azolowo-skondensowanych pirydazyn-3(2h)-onów
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途
JP2021080177A (ja) 2019-11-14 2021-05-27 武田薬品工業株式会社 複素環化合物及びその用途
WO2026060343A1 (en) 2024-09-16 2026-03-19 Neurocrine Biosciences, Inc. Solid forms comprising a nr2b nam antagonist

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2262453A1 (en) 1996-08-27 1998-03-05 Praecis Pharmaceuticals Incorporated Modulators of .beta.-amyloid peptide aggregation comprising d-amino acids
JP2000159747A (ja) * 1998-09-21 2000-06-13 Takeda Chem Ind Ltd 新規チオ―ル誘導体、その製造法および用途
WO2000017162A1 (en) * 1998-09-21 2000-03-30 Takeda Chemical Industries, Ltd. Novel thiol derivatives, process for producing the same and utilization thereof
CA2374346C (en) 1999-06-28 2010-06-22 Jordan J. N. Tang Inhibitors of memapsin 2 and use thereof
EP1235572A2 (en) * 1999-10-29 2002-09-04 MERCK SHARP & DOHME LTD. Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
JPWO2003035641A1 (ja) * 2001-10-22 2005-02-10 塩野義製薬株式会社 新規カルバモイルピロリドン誘導体
JP2004002405A (ja) * 2002-04-26 2004-01-08 Takeda Chem Ind Ltd 新規チオール誘導体、その製造法および用途
WO2003091242A1 (en) * 2002-04-26 2003-11-06 Takeda Pharmaceutical Company Limited Novel thiol derivative, process for producing the same and use thereof
TW200732313A (en) * 2005-12-15 2007-09-01 Astrazeneca Ab Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
TWI403320B (zh) 2005-12-16 2013-08-01 Infinity Discovery Inc 用於抑制ｂｃｌ蛋白和結合夥伴間之交互作用的化合物及方法
WO2009004430A1 (en) * 2007-06-29 2009-01-08 Pfizer Inc. N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
MA39347B2 (fr) 2014-02-24 2020-05-29 Takeda Pharmaceuticals Co Protéines de fusion d'uti
US10174015B2 (en) * 2014-10-31 2019-01-08 Xiamen University Substituted heterocyclic derivative, preparation method and use thereof
EP3636281B1 (en) 2017-05-09 2023-11-01 Zhejiang University Method for treating depression, and pharmaceutical composition
JP6806735B2 (ja) 2018-05-30 2021-01-06 矢崎総業株式会社 車両用回路体および車両用回路体の製造方法
CN118684633A (zh) 2018-10-18 2024-09-24 埃萨制药股份有限公司 雄激素受体调节剂及其使用方法
EP3947353A4 (en) 2019-03-28 2023-07-05 Essa Pharma, Inc. PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS WITH ANDROGEN RECEPTOR INHIBITORS AND THEIR USES
JP2021080177A (ja) 2019-11-14 2021-05-27 武田薬品工業株式会社 複素環化合物及びその用途

Similar Documents

Publication Publication Date Title
JP7846132B2 (ja) Ｎａｖ１．８阻害薬としてのアリール ３－オキソピペラジンカルボキサミド類及びヘテロアリール ３－オキソピペラジンカルボキサミド類
JP7555327B2 (ja) Ｎｌｒｐ３インフラマソーム阻害剤
CN105073747B (zh) 杂环化合物及其应用
JP6832846B2 (ja) ヘテロ環化合物およびその用途
TW570917B (en) Trisubstituted 1,3,5-triazine derivatives
JP2026048891A (ja) Ｎａｖ１．８阻害薬としてのシクロアルキル ３－オキソピペラジンカルボキサミド類及びシクロヘテロアルキル ３－オキソピペラジンカルボキサミド類
JP2015512942A5 (enExample)
RU2472509C2 (ru) Способ лечения артрита
JP2014516360A5 (enExample)
JP2012503018A5 (enExample)
EA033686B1 (ru) Гетероциклические соединения, применимые в качестве модуляторов tnf-альфа
CN105308036A (zh) 用于激酶调节的化合物和方法及其适应症
JP2010513519A5 (enExample)
JP2011509309A5 (enExample)
RU2012131416A (ru) Ингибиторы фосфатидилинозитол-3-киназы на основе изоиндолинона
HRP20131182T1 (hr) Novi derivati 6-triazolopiridazinsulfanilbenzotiazola i -benzimidazola, postupak njihovog dobivanja i primjena kao medikamenata i farmaceutskih pripravaka, te nova upotreba kao inhibitora met
JP2013510884A5 (enExample)
JP2022510925A5 (enExample)
JP2020533352A5 (enExample)
JP2010539166A5 (enExample)
HUE032075T2 (en) 3-(2-aryl-cycloalkenylmethyl)-oxazolidin-2-one derivatives as cholesterol ester transfer protein (cetp) inhibitors
JP2023512664A5 (enExample)
JP2011509301A5 (enExample)
JP2013542267A5 (enExample)
JP2017531680A (ja) 三環式アトロプ異性体の化合物